IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan

Tryptophan catabolism by indoleamine 2,3-dioxygenase (IDO) alters inflammation and favors T-cell tolerance in cancer, but the underlying molecular mechanisms remain poorly understood. The integrated stress response kinase GCN2, a sensor of uncharged tRNA that is activated by amino acid deprivation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Metz, Richard, Rust, Sonja, DuHadaway, James B., Mautino, Mario R., Munn, David H., Vahanian, Nicholas N., Link, Charles J., Prendergast, George C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525601/
https://www.ncbi.nlm.nih.gov/pubmed/23264892
http://dx.doi.org/10.4161/onci.21716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525601/
https://www.ncbi.nlm.nih.gov/pubmed/23264892
http://dx.doi.org/10.4161/onci.21716

Ejemplares similares